Katie J. Doores

Katie J. Doores publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Katie J. Doores sits on this spectrum.

Katie J. Doores D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Katie J. Doores sits on this spectrum.

Best Publications

• Broad neutralization coverage of HIV by multiple highly potent antibodies

  Laura M. Walker;Michael Huber;Michael Huber;Katie J. Doores;Katie J. Doores;Emilia Falkowska;Emilia Falkowska

  1773
  Citations

• Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.

  Jeffrey Seow;Carl Graham;Blair Merrick;Sam Acors

  1214
  Citations

• A dynamic COVID-19 immune signature includes associations with poor prognosis.

  Adam G. Laing;Anna Lorenc;Irene del Molino del Barrio;Irene del Molino del Barrio;Abhishek Das;Abhishek Das

  962
  Citations

• A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

  Robert Pejchal;Katie J. Doores;Katie J. Doores;Laura M. Walker;Reza Khayat

  872
  Citations

• Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.

  Leticia Monin;Adam G Laing;Miguel Muñoz-Ruiz;Duncan R McKenzie

  534
  Citations

• Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers

  Emilia Falkowska;Khoa M. Le;Khoa M. Le;Alejandra Ramos;Alejandra Ramos;Katie J. Doores;Katie J. Doores;Katie J. Doores

  463
  Citations

• Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens

  Katherine Doores;Camille Bonomelli;David J Harvey;Snezana Vasiljevic

  433
  Citations

• Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.

  Michael J. Carter;Michael J. Carter;Matthew Fish;Matthew Fish;Aislinn Jennings;Aislinn Jennings;Katie J. Doores

  429
  Citations

• Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

  Leopold Kong;Jeong Hyun Lee;Katie J Doores;Katie J Doores;Katie J Doores;Charles D Murin

  421
  Citations

• Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.

  Jean-Philippe Julien;Devin Sok;Reza Khayat;Jeong Hyun Lee

  411
  Citations

• Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16

  Katherine Doores;Katherine Doores;Dennis R Burton;Dennis R Burton

  361
  Citations

• Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein

  Anna Janina Behrens;Snezana Vasiljevic;Laura K. Pritchard;David J. Harvey

  284
  Citations

• Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection

  Jeffrey Seow;Carl Graham;Blair Merrick;Sam Acors

  281
  Citations

• The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade

  Camille Bonomelli;Katherine Doores;Katherine Doores;D Cameron Dunlop;Victoria Thaney

  250
  Citations

• The effect of spike mutations on SARS-CoV-2 neutralization.

  Chloe Rees-Spear;Luke Muir;Sarah A. Griffith;Judith Heaney

  221
  Citations

• Exploring and exploiting the therapeutic potential of glycoconjugates

  Katie J. Doores;David. P. Gamblin;Benjamin G. Davis

  211
  Citations

• Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV

  Devin Sok;Devin Sok;Katie J. Doores;Bryan Briney;Bryan Briney;Khoa M. Le;Khoa M. Le

  205
  Citations

• Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.

  Toshana L. Foster;Harry Wilson;Shilpa S. Iyer;Karen Coss

  193
  Citations

• Structural constraints determine the glycosylation of HIV-1 envelope trimers

  Laura K. Pritchard;Snezana Vasiljevic;Gabriel Ozorowski;Gemma E. Seabright

  185
  Citations

• The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.

  Helena Winstone;Maria Jose Lista;Alisha C. Reid;Clement Bouton

  177
  Citations